Table 2—

Percentiles of the standard lipoprotein lipid profile, NMR-determined lipoprotein profile, apolipoprotein levels in sera, and response to in vitro oxidation of LDL from women and men in the DCCT/EDIC cohort in 1997–1999

5–95th percentiles
525507595
WomenReference
 NMR Large VLDL subclass (TG, mg/dl)15.7 (28.7)0.00.32.05.330.0
 NMR Medium VLDL subclass (TG, mg/dl)34.3 (26.7)0.02.58.319.457.2
 NMR Small VLDL subclass (TG, mg/dl)19.2 (11.3)0.04.112.224.343.1
 NMR IDL subclass (cholesterol, mg/dl)4.7 (5.6)0.00.00.02.812.2
 NMR L3 subclass (cholesterol, mg/dl)76.6 (33.7)10.644.067.090.8130.5
 NMR L2 subclass (cholesterol, mg/dl)33.4 (25.7)0.00.022.247.296.8
 NMR L1 subclass (cholesterol, mg/dl)18.5 (18.9)0.00.018.442.978.8
 NMR Large HDL subclass (cholesterol, mg/dl)37.4 (13.8)19.332.542.152.567.9
 NMR Small HDL subclass (cholesterol, mg/dl)15.6 (4.4)2.710.315.019.125.5
 NMR VLDL particle size (nm)44.2 (8.2)33.239.645.856.297.6
 NMR LDL particle size (nm)21.1 (0.5)20.220.721.121.421.8
 NMR HDL particle size (nm)9.4 (0.4)8.68.99.29.610.0
 NMR LDL particle concentration (nmol/l)1,408 (437)8631,1461,3931,6272,114
Men
 NMR Large VLDL subclass (TG, mg/dl)29.2 (41.0)0.00.73.29.659.4
 NMR Medium VLDL subclass (TG, mg/dl)46.2 (31.2)0.05.717.042.399.1
 NMR Small VLDL subclass (TG, mg/dl)20.4 (10.8)0.711.520.630.950.1
 NMR IDL subclass (cholesterol, mg/dl)5.0 (4.7)0.00.00.00.48.6
 NMR L3 subclass (cholesterol, mg/dl)60.9 (34.9)0.022.951.681.8125.6
 NMR L2 subclass (cholesterol, mg/dl)40.7 (26.7)0.07.639.864.8105.4
 NMR L1 subclass (cholesterol, mg/dl)31.9 (25.9)0.00.020.147.8106.8
 NMR Large HDL subclass (cholesterol, mg/dl)23.8 (11.5)8.418.827.236.856.3
 NMR Small HDL subclass (cholesterol, mg/dl)17.4 (4.8)9.015.920.124.528.9
 NMR VLDL particle size (nm)48.1 (9.3)35.240.044.651.273.1
 NMR LDL particle size (nm)20.7 (0.6)19.520.520.921.321.7
 NMR HDL particle size (nm)8.9 (0.4)8.38.68.89.19.6
 NMR LDL particle concentration (nmol/l)1,561 (411)8721,1931,4371,7062,296
  • References for NMR data are mean (SD) for nondiabetic subjects in the Framingham Offspring Study.